no-reflow - Globe Thesis

Keyword [no-reflow] Result: 101 - 120 \| Page: 6 of 10
101.	Effects Of Intracoronary Nitroprusside And Tirofiban Injection On The No-reflow Phenomenon During Percutaneous Coronary Intervention
102.	The Cardioprotective Effect Of Ischemic Postconditioning In Patients Undergoing Primary Percutaneous Coronary Intervention
103.	Effects Of Intracoronary Diltiazem On Coronary No Reflow Penomenon During Emergency Percutaneous Coronary Intervention
104.	The Clinical Research On Predictors Of Coronary No-reflow In Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
105.	The Effects Of Tirofeban Administrated At Various Time Points On No-reflow Phenomenon During Percutaneous Coronary Intervention
106.	The Effect Of Rho Kinase Inhibitor On Endothelial Microparticles And Soluble Intercelluar Adhesion Molecule-1 In Patients With Coronary No-reflow
107.	To Investigate The Effects Of Postconditioning And No Re-flow In Rabbits Models With Acute Myocardial Infarction (AMI) And Reperfusion
108.	Correlative Analysis Between The Serum Irisin Level And No-reflow In Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
109.	Comparasion Between The Effects Of Two Antiplatelet Treatments On Patients With Acute STEMI Undergoing Primary PCI
110.	Inflammatory Factor Induces No-reflow Through Activation Of Cyclooxygenase Signaling Pathway
111.	Meta-analysis Of The Efficacy And Safety Of Intracoronary Administration Of Tirofiban For No-reflow Phenomenon
112.	Cardioprotective Effects Between SK&F96365 And LOE908 To Ischemia/ Reperfusion Injury In Vivo Rabbits
113.	TXL Promotes Human Cardiac Microvascular Endothelial Cells’ Function Partly By Neuregulin-1/ErbB Signaling Pathway
114.	Application Of AngioJet Thrombus-aspirating Device In Patients With Acute ST Segment Elevation Myocardial Infarction And Thrombus-Rich Lesions
115.	The Exploration Of Mechanism Of No-reflow In The Patients With Percutaneous Coronary Intervention Of Acute Coronary Syndrome
116.	Correlation Research Between High-sensitivity C-reactive Protein, Interleukin-6,Tumor Necrosis Factor-alpha And Coronary No-reflow
117.	Clinical Significance Of No-reflow In Different Stages Of Primary Percutaneous Coronary Intervention And Clinical Observation Of Preoperative Strengthening Atorvastatin Therapy
118.	The Observation Of The Effect Of Different Route Of Medicine Administration To Prevent No-reflow For The Patients Suffered With Acute Myocardial Infarction
119.	Analysis Of Risk Factors And Evaluation On Risk Prediction Of No-reflow Phenomenon In Patients Treated With Primary Percutaneous Coronary Intervention For ST-segment Elevation Myocardial Infarction
120.	Tirofiban Induces Vasorelaxation In Coronary Artery Via Endothelium-dependent NO-cGMP Signaling By Activation Of PI3K/Akt/eNOS Pathway
<<First <Prev Next> Last>> Jump to